Loading
A phase 2 trial of adebrelimab in lung cancer, run by Shanghai Hengrui Pharmaceutical Co., Ltd., not yet recruiting.
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC is a phase 2, interventional study registered as NCT07798947 by Shanghai Hengrui Pharmaceutical Co., Ltd., with a registry enrolment figure of 120 participants, started 2026-09 and due to reach its primary completion in 2028-12. Interventions recorded: SHR-7787 Injection; SHR-1316. Conditions listed: Limited-stage Small-cell Lung Cancer. Primary outcome: Incidence and severity of adverse events (AEs); Incidence and severity of serious adverse events (SAEs); Progression-Free Survival (PFS). Lung eligibility wording from the registry: "Histologically or cytologically confirmed unresectable limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following platinum-based chemotherapy and radiation therapy". Sites: China. No results are recorded here; the registry entry is the source.
Shares Limited-stage small-cell lung cancer, Jiangsu Hengrui Pharmaceuticals, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.